Study Finds Popular Cholesterol Drugs Vytorin, Zetia Not Effective Posted By: Katie Kelley A recent study appearing in the New England Journal of Medicine has questioned the effectiveness of the popular cholesterol medication, Vytorin and its sister drug Zetia. Vytorin, a combination of Zetia and the generic drug Zocor, is the second most profitable pharmaceutical manufactured by Merck AND Co. The Securities and Exchange Commission reports that sales of Vytorin and Zetia have raked in an astonishing $21 billion worldwide since 2003. Although ezetimibe, the active ingredient in Vytorin and Zetia, has been shown to reduce cholesterol slightly, its ability to unclog coronary arteries is less than that of niacin, a cheap B vitamin, often available over the counter, according to the article. Additionally, Vytorin and Zetia competitors have been shown to prevent heart attacks, strokes and other cardiovascular diseases at a less expensive price tag, whereas Zetia and Vytorin have not been proven to do either, according to the study. In contrast to Lipitor, Zocor and other statin-type drugs which block cholesterol production in the Liver, Zetia prevents cholesterol absorption in the intestines. The difference between how the drugs reduce cholesterol has helped Zetia’s popularity, despite the fact its effectiveness has been questioned.Vytorin Zetia cholesterol Vytorin news Zetia Lawsuit Vytorin Lawsuit Zetia Class Action Lawsuit Vytorin Class Action Lawsuit Zetia Settlement Vytorin Vytorin Schering-plough, Merck Settle $41.5 Million Class Action Lawsuit Posted By: Katie Kelley The drug research company Schering-Plough and drug manufacturer Merck AND Co. are set to settle one of the largest cases in the companies’ histories. The United States District Court for the District of New Jersey has recently given preliminary approval to a settlement in a class action lawsuit regarding the prescription drugs Zetia and Vytorin. The lawsuit claims that both Merck and Scherin-Plough misrepresented the efficacy of the drugs and thus violated consumer protection laws. The suit claims that the firms marketed both medications as superior alternatives to other available anti-hyperlipidemic and inflated the selling price, thereby misleading doctors, regulators and patients. Evidence also suggests that these medications were no more effective at combating high cholesterol levels than other statin medications. The settlement awards a total of 41.5 million dollars in damages to be split accordingly: $12,450,000 to consumers, $14,525,000 to insurers, and $14,525,000 to insurers who are settling their claims individually. In order to claim a portion of the allocated funds, persons involved in litigation must submit a valid claim form postmarked by April 1, 2010.Zetia Vytorin Zetia Class Action Lawsuit Vytorin Class Action Lawsuit Zetia Settlement Zetia Schering-plough, Merck Settle $41.5 Million Class Action Lawsuit Posted By: Katie Kelley The pharmaceutical companies Schering-Plough and their partner Merck AND Co. have come to a preliminary settlement agreement with lawyers for patients and physicians taking or prescribing the statin drugs Vytorin and Zetia. The United States District Court for the District of New Jersey has given a settlement package preliminary approval; early reports put the cost to the companies at $41.5 million dollars to be split equally among patients, insurance companies, and individual insurance claims. The Zetia AND Vytorin class action lawsuit alleged that the companies misrepresented both drugs in an attempt to boost sales. Claims that the drug was superior to competing anti-hyperlipidemic medications coupled with an inflated selling price were validated in court and the case has been a victory for many patients. The settlement awards a total of 41.5 million dollars in damages to be split accordingly: $12,450,000 to consumers, $14,525,000 to insurers, and $14,525,000 to insurers who are settling their claims individually. In order to claim a portion of the allocated funds, persons involved in litigation must submit a valid claim form postmarked by April 1, 2010.Zetia Vytorin Zetia Lawsuit Vytorin Lawsuit Zetia Class Action Lawsuit Vytorin Class Action Lawsuit Zetia Settlement Vytorin Settlement Zetia 相关的主题文章: